So here is a link to the Silicon Valley Bank review of the Biotech Market. With the recent acquisition of Celgene by Bristol Myers for a whopping price, other acquisitions will follow in our space. At a low valuation, GLG Pharma with its clinical candidates would make a perfect target for an IPO and or an acquisition. Here is the link!!!

Silicon Valley Bank Review Biotech

You'll need to click on the second link to download the PDF copy. Cheers to all!!